Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries has informed that it enclosed a copy of the Press Release about Sun Pharma entering into a global exclusive commercialization, license, and supply agreement for commercializing the specialty product FIBROMUN with Philogen S.p.A, which shall be released after this intimation.

The above information is a part of company’s filings submitted to BSE.